For Akston Bioscienc

For Akston Biosciences and the other new challengers vying for a part of the market, the price of commercial failure is potentially very high. Two years ago Novavax saw a clinical trial for an RSV vaccine crash and burn. The process cost them tens of millions of dollars, resulted in employees being laid off, and the sell-off of two development and manufacturing facilities.

อ่านต่อเพิ่มเติม โรงเรียนบ้านทุ่งแฝก

สาระสำคัญ   อาการท้องผูก